Clinical Characteristics and Overall Survival Among Acute Myeloid Leukemia (AML) Patients with TP53 Gene Mutation (TP53m) or Chromosome 17p Deletion (17p del)

被引：1
|
作者：
Daver, Naval [1 ]
Iqbal, Shahed [2 ]
Huang, Julie [2 ]
Renard, Camille [2 ]
Lin, Joyce [2 ]
Pan, Harry [2 ]
Xing, Guan [2 ]
Pan, Yang [2 ]
Ramsingh, Giri [2 ]
机构：
[1] MD Anderson Canc Ctr, Houston, TX USA
[2] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-170298
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1445 / 1446
页数：2
相关论文
共 50 条
  • [41] P53 GENE-MUTATIONS IN ACUTE MYELOID-LEUKEMIA WITH 17P MONOSOMY
    FENAUX, P
    JONVEAUX, P
    QUIQUANDON, I
    LAI, JL
    PIGNON, JM
    LOUCHEUXLEFEBVRE, MH
    BAUTERS, F
    BERGER, R
    KERCKAERT, JP
    BLOOD, 1991, 78 (07) : 1652 - 1657
  • [42] Treatment of Chronic Lymphocytic Leukemia With del(17p)/TP53 Mutation: Allogeneic Hematopoietic Stem Cell Transplantation or BCR-Signaling Inhibitors?
    Montserrat, Emili
    Dreger, Peter
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 : S74 - S81
  • [43] Acquired uniparental disomy of 17p is associated with mutations of TP53 gene in patients with MDS and complex karyotypes.
    Svobodova, Karla
    Zemanova, Zuzana
    Lhotska, Halka
    Belickova, Monika
    Brezinova, Jana
    Sarova, Iveta
    Izakova, Silvia
    Lizcova, Libuse
    Ransdorfova, Sarka
    Berkova, Adela
    Siskova, Magda
    Jonasova, Anna
    Cermak, Jaroslav
    Michalova, Kyra
    CHROMOSOME RESEARCH, 2015, 23 : S85 - S86
  • [44] 17p Deletion in CLL: Detailed Analysis of TP53 Mutations, Alternative Mechanisms of p53 Inactivation, Clone Size and Clonal Evolution
    Zenz, Thorsten
    Sarno, Antonio
    Haebe, Sonja
    Denzel, Tina
    Mohr, Julia
    Vollmer, Dominik
    Heuberger, Maria
    Winkler, Dirk
    Kienle, Dirk
    Buehler, Andreas
    Truong, Sim
    Patten, Nancy
    Hallek, Michael
    Doehner, Hartmut
    Stilgenbauer, Stephan
    BLOOD, 2008, 112 (11) : 291 - 291
  • [45] FREQUENCY OF 17P ABNORMALITIES IN IRANIAN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML)
    Raftari, Saman
    Mirzaei, Azadeh
    Yaghmaei, Marjan
    Ghavamzadeh, Ardeshir
    PEDIATRIC BLOOD & CANCER, 2018, 65
  • [46] The level of deletion 17p and bi-allelic inactivation of TP53 has a significant impact on clinical outcome in multiple myeloma
    Thanendrarajan, Sharmilan
    Tian, Erming
    Qu, Pingping
    Mathur, Pankaj
    Schinke, Carolina
    van Rhee, Frits
    Zangari, Maurizio
    Rasche, Leo
    Weinhold, Niels
    Alapat, Daisy
    Bellamy, William
    Ashby, Cody
    Mattox, Sandra
    Epstein, Joshua
    Yaccoby, Shmuel
    Barlogie, Bart
    Hoering, Antje
    Bauer, Michael
    Walker, Brian A.
    Davies, Faith E.
    Morgan, Gareth J.
    HAEMATOLOGICA, 2017, 102 (09) : E364 - E367
  • [47] TP53 mutations in myeloid malignancies are either homozygous or hemizygous due to copy number-neutral loss of heterozygosity or deletion of 17p
    M Jasek
    L P Gondek
    N Bejanyan
    R Tiu
    J Huh
    K S Theil
    C O'Keefe
    M A McDevitt
    J P Maciejewski
    Leukemia, 2010, 24 : 216 - 219
  • [48] TP53 mutations in myeloid malignancies are either homozygous or hemizygous due to copy number-neutral loss of heterozygosity or deletion of 17p
    Jasek, M.
    Gondek, L. P.
    Bejanyan, N.
    Tiu, R.
    Huh, J.
    Theil, K. S.
    O'Keefe, C.
    McDevitt, M. A.
    Maciejewski, J. P.
    LEUKEMIA, 2010, 24 (01) : 216 - 219
  • [49] Clinical and Molecular Characteristics of Acute Myeloid Leukemia (AML) Patients with TP53 Mutations and TP73 Mutations
    Mims, Alice S.
    Kohlschmidt, Jessica
    Eisfeld, Ann-Kathrin
    Mrozek, Krzysztof
    Blachly, James S.
    Orwick, Shelley
    Papaioannou, Dimitrios
    Nicolet, Deedra
    Sampath, Deepa
    Stone, Richard M.
    Powell, Bayard L.
    Kolitz, Jonathan E.
    Byrd, John C.
    Bloomfield, Clara D.
    BLOOD, 2018, 132
  • [50] Clinical and prognostic values of TP53 mutation in patients with acute myeloid leukemia
    张莹
    China Medical Abstracts(Internal Medicine), 2020, 37 (01) : 59 - 59
12345